Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway
2008

Poly I:C Boosts Cancer Cell Death via TLR3

publication Evidence: moderate

Author Information

Author(s): Jiang Qun, Wei Haiming, Tian Zhigang

Primary Institution: University of Science and Technology of China

Hypothesis

Does the activation of TLR3 enhance apoptosis in tumor cells when treated with poly I:C and cycloheximide?

Conclusion

The study found that TLR3 activation in tumor cells enhances their sensitivity to apoptosis induced by cycloheximide.

Supporting Evidence

  • TLR3 is widely expressed in various human and murine tumor cell lines.
  • Poly I:C treatment made tumor cells more sensitive to cycloheximide-induced apoptosis.
  • Blockade of TLR3 recognition reduced the proapoptotic effects of poly I:C.

Takeaway

This study shows that a substance called poly I:C can help cancer cells die when used with another drug, making it potentially useful for cancer treatment.

Methodology

The study used RT-PCR and FACS analysis to detect TLR3 expression and assessed cell viability and apoptosis in tumor cells treated with poly I:C and cycloheximide.

Limitations

Some tumor cell lines tested were insensitive to poly I:C or cycloheximide, which may be due to defects in their apoptotic machinery.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-8-12

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication